RADIKO HOLDINGS CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | -.--% |
| Sales 2018 | 107K 8.53M | Sales 2019 | 5.18M 415M | Capitalization | 6.17M 494M |
|---|---|---|---|---|---|
| Net income 2018 | -4M -320M | Net income 2019 | -10M -801M | EV / Sales 2018 | 101 x |
| Net Debt 2018 | 259K 20.71M | Net Debt 2019 | 1.98M 159M | EV / Sales 2019 | 1.57 x |
| P/E ratio 2018 |
-1.5
x | P/E ratio 2019 |
-0.53
x | Employees | - |
| Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 96.73% |
More Fundamentals
* Assessed data
More press releases
1 year
0.00
0.00
3 years
0.000.02
5 years
0.000.36
10 years
0.000.56
| Managers | Title | Age | Since |
|---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 15/04/18 |
David Rosenberg
CTO | Chief Tech/Sci/R&D Officer | - | 09/12/19 |
Scott Reeves
BRD | Director/Board Member | 55 | 31/01/17 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 15/04/18 |
Scott Reeves
BRD | Director/Board Member | 55 | 31/01/17 |
Robert Yosaitis
BRD | Director/Board Member | - | 11/11/19 |
Radiko Holdings Corp., formerly International Cannabrands Inc., is a United States-based company. The Company is a pharmaceutical preparation manufacturer.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 459 | |
| +34.00% | 664B | |
| +29.29% | 567B | |
| -7.75% | 354B | |
| +18.53% | 330B | |
| +4.95% | 286B | |
| +13.79% | 234B | |
| +4.93% | 199B | |
| -9.78% | 196B | |
| -4.89% | 148B |
- Stock Market
- Equities
- GEATF Stock
